Use of gallium‐68 prostate‐specific membrane antigen positron‐emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer …
…, HG van der Poel, ML Donswijk, AN Vis… - BJU …, 2020 - Wiley Online Library
Objectives To review the literature to determine the sensitivity and specificity of gallium‐68
prostate‐specific membrane antigen ( 68 Ga‐PSMA) positron‐emission tomography (PET) for …
prostate‐specific membrane antigen ( 68 Ga‐PSMA) positron‐emission tomography (PET) for …
Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways
AN Vis, FH Schröder - BJU international, 2009 - Wiley Online Library
OBJECTIVE Knowledge of the molecular and cellular changes that occur during the transition
of hormone‐naïve to castration‐resistant prostate cancer (CRPC) is increasing rapidly. …
of hormone‐naïve to castration‐resistant prostate cancer (CRPC) is increasing rapidly. …
Effect on survival of androgen deprivation therapy alone compared to androgen deprivation therapy combined with concurrent radiation therapy to the prostate in …
LMS Boevé, MCCM Hulshof, AN Vis, AH Zwinderman… - European urology, 2019 - Elsevier
… Six patients were excluded because of either a second malignancy (n = 2), absence of
osseous metastases (n = 2), or unknown screening failure (n = 2). Eight patients declined to …
osseous metastases (n = 2), or unknown screening failure (n = 2). Eight patients declined to …
Prostate cancer detection at low prostate specific antigen
…, HJ De Koning, AN Vis… - The Journal of …, 2000 - auajournals.org
Purpose : At low prostate specific antigen (PSA) the indication for prostate biopsy is usually
an abnormal digital rectal examination. We evaluate the diagnostic value of PSA, digital …
an abnormal digital rectal examination. We evaluate the diagnostic value of PSA, digital …
[HTML][HTML] Targeting PSMA revolutionizes the role of nuclear medicine in diagnosis and treatment of prostate cancer
Simple Summary Imaging plays a crucial role in the accurate staging of prostate cancer.
Prostate-specific membrane antigen (PSMA) is overexpressed in prostate cancer cells, and …
Prostate-specific membrane antigen (PSMA) is overexpressed in prostate cancer cells, and …
Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome
BWG Van Rhijn, AN Vis, TH Van Der Kwast… - Journal of clinical …, 2003 - ascopubs.org
Purpose: Fibroblast growth factor receptor 3 (FGFR3) mutations were recently found at a
high frequency in well-differentiated urothelial cell carcinoma (UCC). We investigated the …
high frequency in well-differentiated urothelial cell carcinoma (UCC). We investigated the …
FGFR3 and P53 Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell Carcinoma
BWG Van Rhijn, TH Van Der Kwast, AN Vis, WJ Kirkels… - Cancer research, 2004 - AACR
Fibroblast growth factor receptor 3 (FGFR3) and P53 mutations are frequently observed in
bladder cancer. We here describe the distribution of FGFR3 mutations and P53 …
bladder cancer. We here describe the distribution of FGFR3 mutations and P53 …
Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non–muscle-invasive bladder cancer
BWG Van Rhijn, TCM Zuiverloon, AN Vis, F Radvanyi… - European urology, 2010 - Elsevier
BACKGROUND: The European Organization for Research and Treatment of Cancer (EORTC)
risk scores are not validated in an independent patient population. Molecular grade (mG) …
risk scores are not validated in an independent patient population. Molecular grade (mG) …
[HTML][HTML] Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer
…, RJA van Moorselaar, OS Hoekstra, AN Vis… - European journal of …, 2021 - Springer
Purpose Quantitative prostate-specific membrane antigen (PSMA) PET analysis may provide
for non-invasive and objective risk stratification of primary prostate cancer (PCa) patients. …
for non-invasive and objective risk stratification of primary prostate cancer (PCa) patients. …
Value of an immediate intravesical instillation of mitomycin C in patients with non–muscle-invasive bladder cancer: a prospective multicentre randomised study in …
…, JA Nieuwenhuijzen, T van Ginkel, AN Vis… - European urology, 2018 - Elsevier
Background The efficacy of an immediate single chemotherapy instillation after transurethral
resection of a bladder tumour (TURBT) in patients with non–muscle-invasive bladder …
resection of a bladder tumour (TURBT) in patients with non–muscle-invasive bladder …